Opportunities and challenges in cardiac tissue engineering from an analysis of two decades of advances

RZ Zhuang, R Lock, B Liu… - Nature Biomedical …, 2022‏ - nature.com
Engineered human cardiac tissues facilitate progress in regenerative medicine, disease
modelling and drug development. In this Perspective, we reflect on the most notable …

Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cells

G Campostrini, V Meraviglia, E Giacomelli… - Nature protocols, 2021‏ - nature.com
Tissue-like structures from human pluripotent stem cells containing multiple cell types are
transforming our ability to model and understand human development and disease. Here we …

[HTML][HTML] Vascular cells improve functionality of human cardiac organoids

HK Voges, SR Foster, L Reynolds, BL Parker… - Cell reports, 2023‏ - cell.com
Crosstalk between cardiac cells is critical for heart performance. Here we show that vascular
cells within human cardiac organoids (hCOs) enhance their maturation, force of contraction …

In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid

ME Kupfer, WH Lin, V Ravikumar, K Qiu… - Circulation …, 2020‏ - ahajournals.org
Rationale: One goal of cardiac tissue engineering is the generation of a living, human pump
in vitro that could replace animal models and eventually serve as an in vivo therapeutic …

Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells

E Giacomelli, M Bellin, L Sala, BJ Van Meer… - …, 2017‏ - journals.biologists.com
Cardiomyocytes and endothelial cells in the heart are in close proximity and in constant
dialogue. Endothelium regulates the size of the heart, supplies oxygen to the myocardium …

Establishment of a heart-on-a-chip microdevice based on human iPS cells for the evaluation of human heart tissue function

M Abulaiti, Y Yalikun, K Murata, A Sato, MM Sami… - Scientific reports, 2020‏ - nature.com
Human iPS cell (iPSC)-derived cardiomyocytes (CMs) hold promise for drug discovery for
heart diseases and cardiac toxicity tests. To utilize human iPSC-derived CMs, the …

Naturally engineered maturation of cardiomyocytes

GJ Scuderi, J Butcher - Frontiers in cell and developmental biology, 2017‏ - frontiersin.org
Ischemic heart disease remains one of the most prominent causes of mortalities worldwide
with heart transplantation being the gold-standard treatment option. However, due to the …

The triad of nanotechnology, cell signalling, and scaffold implantation for the successful repair of damaged organs: An overview on soft-tissue engineering

P Abdollahiyan, F Oroojalian… - Journal of controlled …, 2021‏ - Elsevier
As a milestone in therapeutic fields, tissue engineering has offered an alternative strategy to
address unmet clinical needs for the repair and replacement of human damaged organs …

[HTML][HTML] Modeling cardiovascular diseases with hiPSC-derived cardiomyocytes in 2D and 3D cultures

C Sacchetto, L Vitiello, LJ de Windt… - International journal of …, 2020‏ - mdpi.com
In the last decade, the generation of cardiac disease models based on human-induced
pluripotent stem cells (hiPSCs) has become of common use, providing new opportunities to …

The next generation of endothelial differentiation: tissue-specific ECs

J Nguyen, YY Lin, S Gerecht - Cell Stem Cell, 2021‏ - cell.com
Endothelial cells (ECs) sense and respond to fluid flow and regulate immune cell trafficking
in all organs. Despite sharing the same mesodermal origin, ECs exhibit heterogeneous …